Circulating FH Protects Kidneys From Tubular Injury During Systemic Hemolysis

Circulating FH Protects Kidneys From Tubular Injury During Systemic Hemolysis

Intravascular hemolysis of any cause can induce acute kidney injury (AKI). Hemolysis-derived product heme activates the innate immune complement system and contributes to renal damage. Therefore, we explored the role of the master complement regulator Factor H (FH) in the kidney's resistance to...

Full description

Bibliographic Details
Main Authors:	Nicolas S. Merle, Juliette Leon, Victoria Poillerat, Anne Grunenwald, Idris Boudhabhay, Samantha Knockaert, Tania Robe-Rybkine, Carine Torset, Matthew C. Pickering, Sophie Chauvet, Veronique Fremeaux-Bacchi, Lubka T. Roumenina
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2020-08-01
Series:	Frontiers in Immunology
Subjects:	complement – immunological term complement factor H hemolysis kidney acute tubular damage
Online Access:	https://www.frontiersin.org/article/10.3389/fimmu.2020.01772/full

Similar Items

Complement system part I - molecular mechanisms of activation and regulation
by: Nicolas eMerle, et al.
Published: (2015-06-01)

Characterization of Renal Injury and Inflammation in an Experimental Model of Intravascular Hemolysis
by: Nicolas S. Merle, et al.
Published: (2018-03-01)

Both Monoclonal and Polyclonal Immunoglobulin Contingents Mediate Complement Activation in Monoclonal Gammopathy Associated-C3 Glomerulopathy
by: Sophie Chauvet, et al.
Published: (2018-10-01)

Autoantibodies Against C3b—Functional Consequences and Disease Relevance
by: Vasil V. Vasilev, et al.
Published: (2019-01-01)

Heme Drives Susceptibility of Glomerular Endothelium to Complement Overactivation Due to Inefficient Upregulation of Heme Oxygenase-1
by: Olivia May, et al.
Published: (2018-12-01)

Case Report: Adult Post-COVID-19 Multisystem Inflammatory Syndrome and Thrombotic Microangiopathy
by: Idris Boudhabhay, et al.
Published: (2021-06-01)

Complement system part II: role in immunity
by: Nicolas S. Merle, et al.
Published: (2015-05-01)

Haemolytic uraemic syndrome associated with non shiga toxin-producing Escherichia coli bacteraemia: a case report
by: Stéphane Bally, et al.
Published: (2019-05-01)

Three different pathways of IgM-antibody-dependent hemolysis are mainly regulated by complement
by: Thilo Bartolmäs, et al.
Published: (2023-02-01)

Clinical and Genetic Spectrum of a Large Cohort With Total and Sub-total Complement Deficiencies
by: Carine El Sissy, et al.
Published: (2019-08-01)

Eculizumab treatment: stochastic occurrence of C3 binding to individual PNH erythrocytes
by: Michela Sica, et al.
Published: (2017-06-01)

Autoantibodies against Complement Classical Pathway Components C1q, C1r, C1s and C1-Inh in Patients with Lupus Nephritis
by: Maria Radanova, et al.
Published: (2022-08-01)

Heme Interferes With Complement Factor I-Dependent Regulation by Enhancing Alternative Pathway Activation
by: Alexandra Gerogianni, et al.
Published: (2022-07-01)

A Single-Domain Antibody Targeting Complement Component C5 Acts as a Selective Inhibitor of the Terminal Pathway of the Complement System and Thus Functionally Mimicks the C-Terminal Domain of the Staphylococcus aureus SSL7 Protein
by: Laure Yatime, et al.
Published: (2018-11-01)

Pegcetacoplan: A New Opportunity for Complement Inhibition in PNH
by: Weitz IC
Published: (2023-03-01)

Complement in Hemolysis- and Thrombosis- Related Diseases
by: Shanshan Luo, et al.
Published: (2020-07-01)

Structural Basis for Properdin Oligomerization and Convertase Stimulation in the Human Complement System
by: Dennis V. Pedersen, et al.
Published: (2019-08-01)

Paroxysmal Nocturnal Hemoglobinuria: Current Management, Unmet Needs, and Recommendations
by: Oliver M, et al.
Published: (2023-12-01)

Expert consensus on the management of pharmacodynamic breakthrough-hemolysis in treated paroxysmal nocturnal hemoglobinuria
by: David Dingli, et al.
Published: (2024-12-01)

Heme Oxygenase 1: A Defensive Mediator in Kidney Diseases
by: Anne Grunenwald, et al.
Published: (2021-02-01)

Atypical hemolytic and uremic syndrome due to C3 mutation in pancreatic islet transplantation: a case report
by: Thibault Bahougne, et al.
Published: (2020-09-01)

COVID-19 vaccination prevents a more severe course and treatment with complement inhibitors reduce worsening hemolysis during the Omicron pandemic in patients with PNH: a single-center study
by: Leyu Wang, et al.
Published: (2023-12-01)

Thrombocytopenia is not mandatory to diagnose haemolytic and uremic syndrome
by: Sallée Marion, et al.
Published: (2013-01-01)

Rational use of eculizumab in secondary atypical hemolytic uremic syndrome
by: Lucía Cordero, et al.
Published: (2024-01-01)

The efficacy and safety of eculizumab biosimilar in patients with paroxysmal nocturnal hemoglobinuria. Results of a phase III randomized open-label comparative clinical trial
by: Aleksandr D. Kulagin, et al.
Published: (2021-11-01)

Therapeutic Lessons to be Learned From the Role of Complement Regulators as Double-Edged Sword in Health and Disease
by: Esther C. W. de Boer, et al.
Published: (2020-12-01)

Atypical hemolytic uremic syndrome
by: Frémeaux-Bacchi Véronique, et al.
Published: (2011-09-01)

The structure of complement clauses in Lunda
by: Boniface Kawasha
Published: (2006-06-01)

Nrf2 Plays a Protective Role Against Intravascular Hemolysis-Mediated Acute Kidney Injury
by: Alfonso Rubio-Navarro, et al.
Published: (2019-07-01)

Humoral complementomics – exploration of noninvasive complement biomarkers as predictors of renal cancer progression
by: Margot Revel, et al.
Published: (2024-12-01)

Pathological significance of urinary complement activation in diabetic nephropathy: A full view from the development of the disease
by: Jing‐Min Zheng, et al.
Published: (2019-05-01)

Combined Heterozygous Genetic Variations in Complement C2 and C8B: An Explanation for Multidimensional Immune Imbalance?
by: Marco Mannes, et al.
Published: (2023-03-01)

Hipocomplementemia en pacientes con enfermedad de Hodgkin Hypocomplementaemia in patients with Hodgkin disease
Published: (2003-04-01)

Neopterin, PMN Elastase, and Complement Components as Monitoring Parameters in Women with the Syndrome of Hemolysis, Elevated Liver Enzymes and Low Platelet Count
by: Haeger Magnus, et al.
Published: (1993-08-01)

Editorial: The complement system in autoimmunity
by: Eveline Y. Wu, et al.
Published: (2022-11-01)

Severe hemolytic exacerbations of Chinese PNH patients infected SARS‐CoV‐2 Omicron
by: Hui Yang, et al.
Published: (2023-08-01)

THE USE OF DIRECT ANTIGLOBULIN TEST TO DETECT AUTOANTIBODIES IN PATIENTS WITH ANEMIA OF VARIOUS ORIGINS
by: N. V. Mineeva, et al.
Published: (2017-10-01)

Optimization of the Hemolysis Assay for the Assessment of Cytotoxicity
by: Ingvill Pedersen Sæbø, et al.
Published: (2023-02-01)

Investigation of an Acceptable Hemolysis Index Using Re-collected Samples
by: Hong Bum KIM, et al.
Published: (2024-03-01)

Analysis of protein missense alterations by combining sequence‐ and structure‐based methods
by: Aram Gyulkhandanyan, et al.
Published: (2020-04-01)